MEN1 has been reported to act as an oncogenic factor in various solid tumors, such as hepatocellular carcinoma (Kempinska et al., 2018), breast cancer (Dreijerink et al., 2017), and PCa (Kim et al., 2022). This evidence concerns the gene MEN1 and hepatocellular carcinoma.